安信国际 | 康方生物(9926.HK):下一代抗体免疫治疗领域新星

安信国际
Jan 19, 2021

原标题:安信国际 | 康方生物(9926.HK):下一代抗体免疫治疗领域新星 来源:安信国际本文为安信国际近期发布的关于康方生物(9926.HK)的首次覆盖报告,内容摘要如下。康方生物是一家专注于自主研发和商业化创新药的生物医药企业,2012年在广东中山注册成立。公司产品管线丰富,治疗领域涵盖肿瘤和免疫代谢类疾病,特别是基于PD-1靶点的双特异性抗体和单克隆抗体全球领先。20多个在研抗体中,12个...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10